A slowly formed transient conformer of Aβ1-40 is toxic to inward channels of dissociated hippocampal and cortical neurons of rats

Neurobiology of Disease

Volumn 14, Issue 3, 2003, Pages 567-578

  Sun, Xiao Dong ^a   Mo, Zun Li ^b   Taylor, Bruce M ^b   Epps, Dennis E ^b,c  

^a Discov Technol Toxicol P   (United States)

^b PFIZER INC   (United States)

^c Discov Technologies Pharmacia Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CALCIUM CURRENT; CELL ACTIVITY; CELL MEMBRANE DEPOLARIZATION; CELL STRAIN; CELL VIABILITY; COGNITIVE DEFECT; CONTROLLED STUDY; EXPOSURE; FEMALE; HIPPOCAMPUS; INHIBITION KINETICS; MALE; NERVE CELL; NONHUMAN; PEPTIDE ANALYSIS; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RAT; SODIUM CURRENT; STRUCTURE ANALYSIS;

EID: 0347479364     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.08.007     Document Type: Article

References (17)

1. Arispe N., Pollard H.B., Rojas E. Zn2+ interaction with Alzheimer's amyloid beta protein calcium channels. Proc. Natl. Acad. Sci. USA. 93:1996;1710-1715.
2. Bush A.I., Pittingell W.H., Multhaup G., Paradis M.D., Vonsattel J., Gusells J.F., Beyreuther K., Masters C.I., Tanzi R.E. The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding. Science. 265:1994;464-467.
3. Chad J.E., Standford I., Wheal H.V., Williamson R., Woodhall G. Cellular Neurobiology. 1991;19-37 Oxford University Press.
4. Colom L.V., Diaz M.E., Beers D.R., Neely A., Xie W.J., Appel S.H. Role of potassium channels in amyloid-induced cell death. J. Neurochem. 70:1998;1925-1934.
5. Davidson R.M., Shajenko L., Donta T.S. Amyloid beta-peptide (A beta P) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. Brain Res. 643:1994;324-327.
6. Etcheberrigaray E., Ito E., Kim C.S., Alkon D.L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8209-8213.
7. Findeis M.A., Musso G.M., Arico-Muendel C.C., Benjamin H.W., Hundal A.M., Lee J.-J., Chin J., Kelley M., Wakefield J., Hayward N.J., Molineux S. Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry. 38:1999;5791-5800.
8. Frazer S.P., Suh Y.H., Djamgoz Z.A. Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments. Trends Neurosci. 20:1997;67-72.
9. Furukawa K., Barger S.W., Blalock E.M., Mattson M.P. Activation of K+ channels and suppresion of neuronal activity by secreted beta-amyloid-precursor protein. Nature. 379:1996;74-78.
10. Kawahara M., Arispe N., Kuroda Y., Rojas E. Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys. J. 73:1997;67-75.
11. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liostatis M., Morgan T.E., Rozovsky I., Tommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:1998;6448-6553.
12. Lee K.S., Akaike N., Brown A.M. The suction pipette method for internal perfusion and voltage clamp of small excitable cells. J. Neurosci. Methods 2. 1980;51-78.
13. Mattson M.P., Barger S.W., Cheng B., Liberburg I., Smith-Swintosky V.L., Rydel R.E. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;406-415.
14. Mo, Z.L., Sun, X.D., Lee, E.W., Lee, K.S., 2000. Unpublished results.
15. Taylor B.M., Sarver R.W., Fici G.J., Poorman R.A., Lutzke B.S., Molinari A., Kawabe T., Kappenman K., Buhl A.E., Epps D.E. Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40 a kinetic model . J. Protein Chem. 22:2003;31-40.
16. Tollefson G.D. Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia. Biol. Psychiatry. 27:1990;1133-1142.
17. Tseng B.P., Esler W.P., Clish C.B., Stimson E.R., Ghilardi J.R., Vinters H.V., Mantyh P.W., Lee J.P., Maggio J.E. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Biochemistry. 38:1999;10424-10431.